First Capital Inc: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 15, 2023 and accepted by EDGAR at May 15, 2023, 17:30 ET.
Management's discussion and analysis
As filed, 852 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
| Period | (a) Total Number of Shares Purchased | (b) Average Price Paid Per Share | (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs | (d) Maximum Number of Shares that May Yet Be Purchased Under the Plans or Programs |
|---|---|---|---|---|
| January 1 through January 31, 2023 | - | N/A | - | 135,680 |
| February 1 through February 28, 2023 | 12,000 | $27.29 | 12,000 | 123,680 |
| March 1 through March 31, 2023 | - | N/A | - | 123,680 |
| Total | 12,000 | $27.29 | 12,000 |
On August 19, 2008, the board of directors authorized the repurchase of up to 240,467 shares of the Company’s outstanding common stock. The stock repurchase program will expire upon the purchase of the maximum number of shares authorized under the program, unless the board of directors terminates the program earlier.
Risk factors
As filed, 188 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the risk factors previously disclosed in the “Risk Factors” section of the Company’s Annual Report on Form 10-K for the year ended December 31, 2022.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $1.7m | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $4.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $996.0k | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $769.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $3.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $1.14 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $1.14 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 3,353,623 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-01-01 to 2023-03-31 | $5.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-01-01 to 2023-03-31 | $132.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-01-01 to 2023-03-31 | $907.0k | us-gaap:PaymentsOfDividends |
| Share repurchases | 3 months2023-01-01 to 2023-03-31 | $327.0k | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2023-03-31 | $1.14bn | us-gaap:Assets |
| Total liabilities | At period end2023-03-31 | $1.04bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2023-03-31 | $94.0m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001171843-23-003319. Last ingested by Listed: Nov 6, 2026, 18:07 ET. Listed shows no prices and gives no investment advice.